Lung Cancer

Question 1

FDA approved molecular targets and drugs in lung cancer by end 2014

Answer 1

ALL END IN -INIB EFGR mutations: Erloinib, Gefitinib, Afatinib
Anaplastic Lumphoma Kinase: Crizotinib, Certinib

Question 2

_______ over-expressed at the earliest stages of lung cancer developement

Answer 2

EGFR/HER2